Pulmonary Embolism Second Edition by Paul Stein ISBN 9781405138079 1405138079

Pulmonary Embolism Second Edition by Paul D. Stein – Ebook PDF Instant Download/Delivery: 9781405138079, 1405138079 
Full download Pulmonary Embolism Second Edition after payment

Product details: 

ISBN 10:  1405138079 

ISBN 13: 9781405138079

Author: Paul D. Stein

“…the best book I’ve seen on this topic”
— William C. Roberts, MD, Editor in Chief of the American Journal of Cardiology, in a review of the first edition

This second edition supplies the latest information on epidemiology, methods of diagnosis, preferred diagnostic pathways, new medications, and new recommendations for prophylaxis and treatment of pulmonary embolism and its immediate cause, deep vein thrombosis.

Pulmonary Embolism, Second Edition, incorporates important data from the recent Prospective Investigation of Pulmonary Embolism Diagnosis II (PIOPED II), including:

• new clinical observations
• accuracy of multidetector computed tomography for the diagnosis of acute pulmonary embolism
• recommendations for the use of various imaging tests according to the characteristics of the patient

Every chapter of the book has been revised and updated, and 56 new chapters appear in this edition. Through the writing ability of its single author, the text remains as easy to read as it is to consult.

This book is a timely reference and a dependable resource for in-depth information about pulmonary embolism.

Table of contents: 

Part I. Prevalence, Risks, and Prognosis of Pulmonary Embolism and Deep Venous Thrombosis

1. Pulmonary embolism and deep venous thrombosis at autopsy

2. Incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients and in emergency departments

3. Case fatality rate and population mortality rate from pulmonary embolism and deep venous thrombosis

4. Prognosis in acute pulmonary embolism based on right ventricular enlargement and biochemical markers in stable patients

5. Prognosis in acute pulmonary embolism based on scoring systems

6. Pulmonary embolism following deep venous thrombosis and outcome with untreated pulmonary embolism

7. Resolution of pulmonary embolism

8. Upper extremity deep venous thrombosis

9. Thromboembolic disease involving the superior vena cava and brachiocephalic veins

10. Venous thromboembolic disease in the four seasons

11. Regional differences in the United States of rates of diagnosis of pulmonary embolism and deep venous thrombosis and mortality from pulmonary embolism

12. Venous thromboembolism according to age and in the elderly

13. Pulmonary thromboembolism in infants and children

14. Venous thromboembolism in men and women

15. Pulmonary embolism and deep venous thrombosis in blacks and whites

16. Pulmonary thromboembolism in Asians/Pacific Islanders

17. Pulmonary thromboembolism in American Indians and Alaskan Natives

18. Venous thromboembolism in patients with cancer

19. Venous thromboembolism in patients with heart failure

20. Obesity as a risk factor in venous thromboembolism

21. Hypertension, smoking, and cholesterol

22. Overlap of venous and arterial thrombosis risk factors

23. Venous thromboembolism in patients with ischemic and hemorrhagic stroke

24. Paradoxical embolism

25. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease

26. Pulmonary embolism and deep venous thrombosis in hospitalized patients with asthma

27. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease

28. Diabetes mellitus and risk of venous thromboembolism

29. Risk of venous thromboembolism with rheumatoid arthritis

30. Venous thromboembolism with inflammatory bowel disease

31. Venous thromboembolism with chronic liver disease

32. Nephrotic syndrome

33. Human immunodeficiency virus infection

34. Venous thromboembolism in pregnancy

35. Amniotic fluid embolism

36. Air travel as a risk for pulmonary embolism and deep venous thrombosis

37. Estrogen-containing oral contraceptives and venous thromboembolism

38. Estrogen and testosterone in men

39. Tamoxifen

40. Venous thromboembolism following bariatric surgery

41. Hypercoagulable syndrome

---

Part II. Diagnosis of Deep Venous Thrombosis

42. Deep venous thrombosis of the lower extremities: clinical evaluation

43. Clinical scoring system for assessment of deep venous thrombosis

44. Clinical probability score plus single negative ultrasound for exclusion of deep venous thrombosis

45. D-dimer for the exclusion of acute deep venous thrombosis

46. D-dimer combined with clinical probability assessment for exclusion of acute deep venous thrombosis

47. D-dimer and single negative compression ultrasound for exclusion of deep venous thrombosis

48. Contrast venography

49. Compression ultrasound for the diagnosis of deep venous thrombosis

50. Impedance plethysmography and fibrinogen uptake tests for diagnosis of deep venous thrombosis

51. Ascending CT venography and venous phase CT venography for diagnosis of deep venous thrombosis

52. Magnetic resonance venography for diagnosis of deep venous thrombosis

53. P-selectin and microparticles to predict deep venous thrombosis

---

Part III. Diagnosis of Acute Pulmonary Embolism

54. Clinical characteristics of patients with no prior cardiopulmonary disease

55. Relation of right-sided pressures to clinical characteristics of patients with no prior cardiopulmonary disease

56. The history and physical examination in all patients irrespective of prior cardiopulmonary disease

57. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes

58. Clinical assessment in the critically ill

59. The electrocardiogram

60. The plain chest radiograph

61. Arterial blood gases and the alveolar–arterial oxygen difference in acute pulmonary embolism

62. Fever in acute pulmonary embolism

63. Leukocytosis in acute pulmonary embolism

64. Alveolar dead-space in the diagnosis of pulmonary embolism

65. Empirical assessment and clinical models for diagnosis of acute pulmonary embolism

66. Prognostic models for pulmonary embolism

67. D-dimer for the exclusion of acute pulmonary embolism

68. D-dimer combined with clinical probability for exclusion of acute pulmonary embolism

69. D-dimer in combination with amino-terminal pro-B-type natriuretic peptide for exclusion of acute pulmonary embolism

70. Tissue plasminogen activator, plasminogen activator inhibitor-1, and thrombin–antithrombin III complexes in the exclusion of acute pulmonary embolism

71. Echocardiogram in the diagnosis of acute pulmonary embolism

72. Trends in the use of diagnostic imaging in patients hospitalized with acute pulmonary embolism

73. Techniques of perfusion and ventilation imaging

74. Ventilation–perfusion lung scan criteria for interpretation prior to PIOPED

75. Observations from PIOPED: ventilation–perfusion lung scans alone and with clinical assessment

76. Ventilation–perfusion lung scans according to complexity of lung disease

77. Perfusion lung scans alone in acute pulmonary embolism

78. Probability interpretation based on largest pulmonary arterial branches

79. Revised criteria for evaluation of lung scans (PIOPED recommendations)

80. Criteria for very-low-probability ventilation–perfusion lung scans

81. Probability assessment based on mismatched segmental perfusion defects

82. Probability assessment based on mismatched vascular defects and prior cardiopulmonary disease

83. Clinical assessment combined with prior cardiopulmonary disease for scan interpretation

84. Pulmonary scintigraphy scans since PIOPED

85. SPECT lung scans

86. SPECT with radiolabeled markers

87. Standard and augmented techniques in pulmonary angiography

88. Subsegmental pulmonary embolism

89. Quantification of pulmonary embolism by angiography and CT

90. Complications of pulmonary angiography

91. Contrast-enhanced spiral CT before PIOPED II

92. Methods of PIOPED II

93. Multidetector CT pulmonary angiography: PIOPED II results

94. CT pulmonary angiography since PIOPED II

95. Outcome studies of pulmonary embolism versus accuracy

96. Contrast-induced nephropathy

97. Radiation exposure and risk

98. Magnetic resonance angiography

99. Serial noninvasive leg tests in suspected pulmonary embolism

100. Diagnosis of pulmonary embolism in the coronary care unit

101. Silent pulmonary embolism with deep venous thrombosis

102. Fat embolism syndrome

103. Diagnostic approach to acute pulmonary embolism

---

Part IV. Prevention and Treatment of Deep Venous Thrombosis and Pulmonary Embolism

104. Warfarin and other vitamin K antagonists

105. Unfractionated heparin, low-molecular-weight heparin, heparinoid, and pentasaccharide

106. Parenteral inhibitors of factors Va, VIIIa, tissue factor, and thrombin

107. Novel oral anticoagulants

108. Aspirin for venous thromboembolism

109. Immediate therapeutic levels of heparin and timing of recurrent events

110. Intermittent pneumatic compression

111. Graduated compression stockings

112. Ankle exercise and venous blood velocity

113. Thrombolytic therapy for deep venous thrombosis

114. Mechanical and ultrasonic enhancement of catheter-directed thrombolytic therapy

115. Thrombolytic therapy for acute pulmonary embolism

116. Catheter-tip embolectomy in acute massive pulmonary embolism

117. Vena cava filters

118. Withholding treatment of acute pulmonary embolism in high-bleeding-risk patients with negative serial noninvasive leg tests

119. Home treatment of deep venous thrombosis

120. Home treatment of acute pulmonary embolism

121. Pulmonary embolectomy

122. Chronic thromboembolic pulmonary hypertension and pulmonary thromboendarterectomy

123. ACCP Guidelines for prevention and treatment of deep venous thrombosis and acute pulmonary embolism

People also search for:

bilateral pulmonary embolism
    
acute pulmonary embolism
    
stages of pulmonary embolism
    
what does a pulmonary embolism feel like
    
history of pulmonary embolism icd 10

Tags: Paul Stein, Pulmonary Embolism